Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study — GEN100  

Ageing Clinical Trial

Official title: Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study

Status Active, not recruiting

Clinical Trial Summary

Hypothesis: Exercise will reduce morbidity and mortality rates in an elderly population. The extent of reduction will be intensity dependent.

Clinical Trial Description

Literature lacks large controlled randomized studies that look at the effect of exercise training on morbidity and mortality. Generation 100 will be the first randomized, controlled clinical study where the primary objective is to study the effects of exercise training on morbidity and mortality in the elderly. Furthermore, the researchers will investigate whether there is a relationship between the exercise intensity and health benefits, with particular focus on major health problems in the elderly population. In addition to being a study, this is also an initiative to improve public health in all healthy individuals between 70-75 years of age in the Trondheim municipality. The participants will either be randomized to supervised exercise or follow current guidelines for physical activity on their own. Clinical examinations, as well as questionnaires, will be administered to all participants at baseline, after one year, after three years, and after five years. Additionally, participants will be followed-up by linking to relevant registers for up to 20 years.

Also data will be collected with the purposes of (a) investigating genetic predisposition for fitness and cardiovascular diseases, and (b) identification of potential targets for therapies.

The study seeks to determine if exercise training gives the seniors a longer active and healthy life. ;

Related Conditions & MeSH terms

• Ageing

• NCT number: NCT01666340
• Study type: Interventional
• Source: Norwegian University of Science and Technology
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 21, 2012
• Completion date: June 2023